Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million

Femasys received FDA approval to advance the final phase of its FemBloc pivotal trial, alongside $12 million in financing with potential to reach $58 million.